GENEVA, Switzerland I April 17, 2025 I Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of ...

These talented and inspirational athletes each has a story worth sharing — and a powerful reason for their 26.2 mile journey.

The society is planning to use this sanctuary as a model for more sanctuaries across the nation, said Robin Ganzert, ...

The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer’s disease and mild traumatic brain injury. It also develops ALPHA-0602, a gene therapy for the ...

Stanford researchers found that a single dose of ibogaine may dramatically reduce PTSD and TBI symptoms in veterans—offering ...

Nasal Spray Shows Preclinical Promise for Treating Traumatic Brain Injury Feb. 27, 2025 — A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective ...

signs of brain injury that are associated with memory and ... Apr. 9, 2025 — Over the last two decades, ischemic stroke mortality rates in the U.S. have grown, with almost 3 in 10 deaths ...